First patient enrolled in Phase 3 trial of mocertatug rezetecan for platinum-resistant ovarian cancer
Philadelphia, PA, USA — July 27, 2026 — The GOG Foundation, Inc. announced the enrollment of the first patient in ...
Philadelphia, PA, USA — July 27, 2026 — The GOG Foundation, Inc. announced the enrollment of the first patient in ...
In a groundbreaking stride against one of oncology's most formidable challenges, researchers have unveiled promising clinical trial results exploring novel ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine